Carboplatin/Paclitaxel Clinical Trials
3 recruitingDrug
Phase 23
Showing 1–3 of 3 trials
Recruiting
Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Non-small Cell Lung Cancer
AstraZeneca630 enrolled99 locationsNCT05061550
Recruiting
Phase 2
A Phase II Study of SSGJ-706 Monotherapy and Combination Therapy in Advanced Non-Small Cell Lung Cancer（NSCLC） Patients
First-line Advanced NSCLC Patients
Shenyang Sunshine Pharmaceutical Co., LTD.240 enrolled1 locationNCT07171606
Recruiting
Phase 2
Carboplatin/Paclitaxel + Pembrolizumab for Locoregionally Advanced Penile Cancer
Penile CancerUrogenital NeoplasmsPenile Squamous Cell Carcinoma+3 more
The Netherlands Cancer Institute27 enrolled2 locationsNCT06353906